We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.06B
AUM Growth
-$17.6M
(-0.85%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-6.91%
Top 10 Holdings %
Top 10 Hldgs %
39.12%
Holding
172
New
46
Increased
26
Reduced
29
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$76.5M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$46M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$45.8M |
| 4 |
Molson Coors Class A
TAP.A
|
+$37.2M |
| 5 |
Alcoa
AA
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$63.9M |
| 2 |
Axalta
AXTA
|
+$58.4M |
| 3 |
Adobe
ADBE
|
+$39.7M |
| 4 |
PayPal
PYPL
|
+$38.4M |
| 5 |
Devon Energy
DVN
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.67% |
| 2 | Consumer Staples | 9.08% |
| 3 | Industrials | 8.37% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENTL
76
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.05M | 0.25% |
299,268
+29,268
| +11% | +$497K |
|
77
Emergent Biosolutions
EBS
$394M
| $4.81M | 0.23% |
120,142
-287,700
| -71% | -$10M |
|
78
Nexstar Media Group
NXST
$5.9B
| $4.78M | 0.23% |
+81,502
| New | +$4.5M |
|
79
Edgewell Personal Care
EPC
$1.38B
| $4.56M | 0.22% |
+58,151
| New | +$4.71M |
|
80
Zevra Therapeutics
ZVRA
$620M
| $4.04M | 0.2% |
12,712
-4,188
| -25% | -$1.14M |
|
|
CEMP
81
DELISTED
Cempra, Inc.
CEMP
| $3.72M | 0.18% |
119,400
+69,400
| +139% | +$1.93M |
|
82
Kraft Heinz
KHC
$30.5B
| $3.64M | 0.18% |
+50,000
| New | +$3.69M |
|
83
CVS Health
CVS
$125B
| $3.6M | 0.18% |
+36,815
| New | +$3.61M |
|
|
CAFD
84
DELISTED
8point3 Energy Partners LP
CAFD
| $3.55M | 0.17% |
+220,000
| New | +$2.95M |
|
|
MBLY
85
DELISTED
Mobileye N.V.
MBLY
| $3.38M | 0.16% |
+80,000
| New | +$3.58M |
|
86
PUT
Enanta Pharmaceuticals
ENTA
$391M
| $3.3M | 0.16% |
+100,000
| New | +$3.26M |
|
|
OTIC
87
DELISTED
Otonomy, Inc.
OTIC
| $3.26M | 0.16% |
117,587
+7,587
| +7% | +$189K |
|
88
Lipocine
LPCN
$18.2M
| $3.15M | 0.15% |
14,343
-3,010
| -17% | -$631K |
|
|
ALPN
89
DELISTED
Alpine Immune Sciences Inc
ALPN
| $3.09M | 0.15% |
99,916
-4,810
| -5% | -$164K |
|
90
Exelixis
EXEL
$14.2B
| $3.04M | 0.15% |
539,130
-280,870
| -34% | -$1.57M |
|
91
Monolithic Power Systems
MPWR
$65.2B
| $2.92M | 0.14% |
45,792
-34,670
| -43% | -$2.15M |
|
|
IL
92
DELISTED
IntraLinks Holdings Inc.
IL
| $2.88M | 0.14% |
317,032
-30,000
| -9% | -$277K |
|
|
ZLTQ
93
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $2.85M | 0.14% |
+100,000
| New | +$3.16M |
|
|
ANAC
94
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.82M | 0.14% |
25,000
-75,000
| -75% | -$8.26M |
|
|
UNIT
95
Uniti Group
UNIT
$2.39B
| $2.8M | 0.14% |
+150,000
| New | +$2.89M |
|
|
IVTY
96
DELISTED
Invuity, Inc
IVTY
| $2.67M | 0.13% |
302,650
+650
| +0.2% | +$7.71K |
|
|
ATRS
97
DELISTED
Antares Pharma, Inc.
ATRS
| $2.45M | 0.12% |
2,023,868
+58,130
| +3% | +$80.9K |
|
98
Radware
RDWR
$1.21B
| $2.36M | 0.11% |
+153,900
| New | +$2.35M |
|
|
WWAV
99
DELISTED
The WhiteWave Foods Company
WWAV
| $1.96M | 0.1% |
+50,300
| New | +$2.04M |
|
|
CBAY
100
DELISTED
Cymabay Therapeutics
CBAY
| $1.68M | 0.08% |
993,920
+43,920
| +5% | +$71.6K |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Kingdon Capital Management held 172 positions worth $2.06B, down 0.85% from $2.07B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Kingdon Capital Management withdrew a net $142M in Q4 2015, closing 58 positions and reducing 29 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $63.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Kingdon Capital Management opened a new position in Alphabet (Google) Class A worth $80.4M.
- Kingdon Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 2,067,600 shares worth $80.4M.
- Kingdon Capital Management added most to ANACOR PHARMACEUTICALS INC COM in Q4 2015, an estimated $46M increase.
- Kingdon Capital Management's biggest Q4 2015 reduction was Visteon, cutting an estimated $22.1M.
- Kingdon Capital Management fully exited Alphabet (Google) Class C in Q4 2015, selling an estimated $63.9M.
- Kingdon Capital Management's ten largest holdings make up 39% of its $2.06B portfolio in Q4 2015.
- Kingdon Capital Management opened 46 new positions and closed 58 in Q4 2015.
- Kingdon Capital Management's portfolio value fell 0.85% quarter-over-quarter to $2.06B.
Based on Kingdon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.